FRONTIER CAPITAL MANAGEMENT CO LLC – United Therapeutics Corporation Transaction History
FRONTIER CAPITAL MANAGEMENT CO LLC portfolio value:
$39.18M
portfolio value
FRONTIER CAPITAL MANAGEMENT CO LLC quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -12.01% | -25.55K shares | -10.93M | $209.38 | 187.13K |
Q2 2022 | share | Increase | +18.50% | 33.20K shares | 17.91M | $235.64 | 212.68K |
Q1 2022 | share | Decrease | -8.61% | -16.91K shares | -10.23M | $179.41 | 179.47K |
Q4 2021 | share | Increase | +124.54% | 108.92K shares | 26.29M | $215.18 | 196.38K |
Q3 2021 | share | Decrease | -20.54% | -22.61K shares | -3.60M | $184.58 | 87.46K |
Q2 2021 | share | Decrease | -14.47% | -18.63K shares | -1.77M | $179.41 | 110.07K |
Q1 2021 | share | Increase | +341.89% | 99.57K shares | 17.10M | $167.27 | 128.70K |
Q4 2020 | share | Decrease | -11.12% | -3.64K shares | 1.11M | $151.79 | 29.12K |
Q3 2020 | share | Decrease | -28.44% | -13.02K shares | -2.23M | $101 | 32.77K |
Q2 2020 | share | Increase | +15.59% | 6.17K shares | 1.78M | $121 | 45.79K |
Q1 2020 | share | Increase | 0.00% | 39.61K shares | 3.75M | $94.83 | 39.61K |
Q1 2017 | share | Decrease | -100.00% | -139.26K shares | -19.97M | $135.38 | 0 |
Q4 2016 | share | Increase | +121.39% | 76.36K shares | 12.54M | $143.43 | 139.26K |
Q3 2016 | share | Decrease | -8.73% | -6.01K shares | 128K | $118.08 | 62.90K |
Q2 2016 | share | Increase | +79.36% | 30.49K shares | 3.01M | $105.92 | 68.91K |
Q1 2016 | share | Decrease | -20.33% | -9.80K shares | -3.27M | $111.43 | 38.42K |